title: Long term experience in the treatment of advanced prostatic cancer with decapeptyl, compared to orchiectomy.
authors.forename: W A
authors.initials: WA
authors.lastname: De Sy
authors.forename: P
authors.initials: P
authors.lastname: De Wilde
authors.forename: J M
authors.initials: JM
authors.lastname: De Meyer
authors.forename: J
authors.initials: J
authors.lastname: Casselman
authors.forename: R
authors.initials: R
authors.lastname: Desmet
authors.forename: G
authors.initials: G
authors.lastname: Renders
authors.forename: W
authors.initials: W
authors.lastname: Schelfhout
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004341:Drug Evaluation; D007987:Gonadotropin-Releasing Hormone / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D009919:Orchiectomy; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000601:surgery; D011897:Random Allocation; D017329:Triptorelin Pamoate
chemical_list: D000970:Antineoplastic Agents; D017329:Triptorelin Pamoate; D007987:Gonadotropin-Releasing Hormone